Cardiomyopathy

Martha-Gulati.jpg
ESC: Tafamidis Cuts Deaths, Admissions in TTR Cardiac Amyloidosis
Treatment with the investigational drug tafamidis was associated with a reduction in all-cause mortality and cardiovascular hospitalizations in patients with…
Read more
pfizer_logo.jpg
US FDA Accepts Regulatory Submissions for Review of Tafamidis to Treat Transthyretin Amyloid Cardiomyopathy
Pfizer Inc. announced today that the US Food and Drug Administration (FDA) accepted for filing the company's New Drug Applications (NDAs) for tafamidis for the…
Read more
Subscribe to